CZO Share Price

Open 1.66 Change Price %
High 1.75 1 Day 0.07 4.32
Low 1.63 1 Week 0.12 7.64
Close 1.69 1 Month 0.05 3.05
Volume 350649 1 Year 1.29 322.50
52 Week High 2.47
52 Week Low 0.40
CZO Important Levels
Resistance 2 1.80
Resistance 1 1.76
Pivot 1.69
Support 1 1.62
Support 2 1.58
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
MCG 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
BVQ 0.02 100.00%
ZMD 0.02 100.00%
DDX 0.50 100.00%
PTR 0.02 100.00%
PTR 0.02 100.00%
PTR 0.02 100.00%
SVT 0.04 100.00%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
IXI 0.02 -50.00%
KLM 0.01 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Ceapro Inc (CVE: CZO)

CZO Technical Analysis 1.5
As on 22nd Feb 2017 CZO Share Price closed @ 1.69 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.49 & Sell for SHORT-TERM with Stoploss of 1.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
CZO Target for February
1st Target up-side 1.82
2nd Target up-side 1.99
3rd Target up-side 2.15
1st Target down-side 1.36
2nd Target down-side 1.19
3rd Target down-side 1.03
CZO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.ceapro.com
CZO Address
CZO
Enterprise Square
Suite 4174
Edmonton, AB T5J 4P6
Canada
Phone: 780-421-4555
Fax: 780-421-1320
CZO Latest News
Fabrice Taylor: This Canadian biotech firm may be a hidden gem   The Globe and Mail   - 15th Dec 16
Ceapro (CZO.V): New Facility Opens; Topline Takes a Break   Zacks Small Cap Research (press release)   - 05th Dec 16
Ceapro: A Small, Profitable, Fast-Growing Biotechnology Company   Seeking Alpha   - 04th Nov 16
Ceapro's new biotech facility applauded by premier as model of economic ...   Edmonton Journal   - 29th Sep 16
Gary Lamphier: Ceapro leads local stocks to healthy first-half gains   Edmonton Journal   - 05th Jul 16
Province plans $10-million expansion of Edmonton-area food processing incubator   Edmonton Journal   - 15th Jun 16
Ceapro Inc. Announces Brokered Private Placement   Marketwired (press release)   - 09th Jun 16
Ceapro Inc. Issued US Patent for Enabling PGX Technology   Pharmaceutical Processing   - 03rd Feb 16
Ceapro Inc. to Present at Biotech Showcase™ 2017   Marketwired (press release)   - 05th Jan 16
This small company has a great idea but not enough sales   The Globe and Mail   - 16th May 15
Interactive Technical Analysis Chart Ceapro Inc ( CZO CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Ceapro Inc
CZO Business Profile
Ceapro Inc., a biotechnology company, engages in the development and commercialization of health and wellness products and technology relating to plant extracts primarily in the United States, Germany, and Canada. The company markets natural active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; and veterinary therapeutic products comprising an oat shampoo, an ear cleanser, and a dermal complex/conditioner for veterinarians in Japan and Asia. Its products and technologies under research and development, or pre-commercial stage include CeaProve, a diabetes test meal to screen pre-diabetes and to confirm diabetes diagnosis; a drug delivery platform using its beta glucan technology delivers compounds for uses ranging from wound care and therapy to skin care treatments that reduce the signs of aging; an extension to the active ingredients product range; and various novel manufacturing technologies. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.